Target Price | $36.40 |
Price | $2.89 |
Potential |
1,159.49%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Silence Therapeutics Plc - ADR 2026 .
The average Silence Therapeutics Plc - ADR target price is $36.40.
This is
1,159.49%
register free of charge
$75.64
2,517.30%
register free of charge
$4.09
41.68%
register free of charge
|
|
A rating was issued by 6 analysts: 5 Analysts recommend Silence Therapeutics Plc - ADR to buy, 0 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Silence Therapeutics Plc - ADR stock has an average upside potential 2026 of
1,159.49%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 43.28 | 35.82 |
36.23% | 17.23% | |
EBITDA Margin | -113.24% | -215.92% |
30.83% | 90.68% | |
Net Margin | -106.90% | -96.20% |
51.06% | 10.01% |
6 Analysts have issued a sales forecast Silence Therapeutics Plc - ADR 2025 . The average Silence Therapeutics Plc - ADR sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Silence Therapeutics Plc - ADR EBITDA forecast 2025. The average Silence Therapeutics Plc - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Silence Therapeutics Plc - ADR 2025 . The average Silence Therapeutics Plc - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.98 | -0.73 |
33.33% | 25.51% | |
P/E | negative | |
EV/Sales | negative |
1 Analysts have issued a Silence Therapeutics Plc - ADR forecast for earnings per share. The average Silence Therapeutics Plc - ADR EPS is
This results in the following potential growth metrics and future valuations:
Silence Therapeutics Plc - ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.